Alternative Pharmaceutical Formulation for Oral Administration of Rifampicin
ASSAY and Drug Development Technologies · 2018-12 · 16 (8) · 456-461
DOI: 10.1089/adt.2018.874 ↗Kurz gefasst
Fachartikel in der Zeitschrift ASSAY and Drug Development Technologies, 2018-12. Verfasst von Priscila Cristina Bartolomeu Halicki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Núcleo de Pesquisa em Microbiologia Médica, Faculdade de Medicina, Universidade Federal do Rio Grande-FURG, Rio Grande, Brazil. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Núcleo de Pesquisa em Microbiologia Médica, Faculdade de Medicina, Universidade Federal do Rio Grande-FURG, Rio Grande, Brazil.
- Laboratório de Nanotecnologia, Centro de Microscopia Eletrônica da Zona Sul, Universidade Federal do Rio Grande-FURG, Rio Grande, Brazil.
Zitieren
APA
Halicki, P. C. B., Hädrich, G., Boschero, R., Ferreira, L. A., von Groll, A., da Silva, P. E. A., Dora, C. L., & Ramos, D. F. (2018). Alternative Pharmaceutical Formulation for Oral Administration of Rifampicin. ASSAY and Drug Development Technologies, 16(8), 456-461. https://doi.org/10.1089/adt.2018.874
Vancouver
Halicki PCB, Hädrich G, Boschero R, Ferreira LA, von Groll A, da Silva PEA, et al. Alternative Pharmaceutical Formulation for Oral Administration of Rifampicin. ASSAY and Drug Development Technologies. 2018;16(8):456-461. doi:10.1089/adt.2018.874
BibTeX
@article{Halicki2018,
author = {Halicki, Priscila Cristina Bartolomeu and Hädrich, Gabriela and Boschero, Raphael and Ferreira, Laís Andrade and von Groll, Andrea and da Silva, Pedro Eduardo Almeida and Dora, Cristiana Lima and Ramos, Daniela Fernandes},
title = {Alternative Pharmaceutical Formulation for Oral Administration of Rifampicin},
journal = {ASSAY and Drug Development Technologies},
year = {2018},
volume = {16},
number = {8},
pages = {456--461},
doi = {10.1089/adt.2018.874}
}
EUVIMED